Skip to main content
Top
Published in: Critical Care 5/2004

Open Access 01-10-2004 | Research

Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care

Authors: Mark D Williams, Lee Ann Braun, Liesl M Cooper, Joseph Johnston, Richard V Weiss, Rebecca L Qualy, Walter Linde-Zwirble

Published in: Critical Care | Issue 5/2004

Login to get access

Abstract

Introduction

Infection is an important complication in cancer patients, which frequently leads to or prolongs hospitalization, and can also lead to acute organ dysfunction (severe sepsis) and eventually death. While cancer patients are known to be at higher risk for infection and subsequent complications, there is no national estimate of the magnitude of this problem. Our objective was to identify cancer patients with severe sepsis and to project these numbers to national levels.

Methods

Data for all 1999 hospitalizations from six states (Florida, Massachusetts, New Jersey, New York, Virginia, and Washington) were merged with US Census data, Centers for Disease Control vital statistics and National Cancer Institute, Surveillance, Epidemiology, and End Results initiative cancer prevalence data. Malignant neoplasms were identified by International Classification of Disease (ninth revision, clinical modification) (ICD-9-CM) codes (140–208), and infection and acute organ failure were identified from ICD-9-CM codes following Angus and colleagues. Cases were identified as a function of age and were projected to national levels.

Results

There were 606,176 cancer hospitalizations identified, with severe sepsis present in 29,795 (4.9%). Projecting national estimates for the US population, cancer patients account for 126,209 severe sepsis cases annually, or 16.4 cases per 1000 people with cancer per year. The inhospital mortality for cancer patients with severe sepsis was 37.8%. Compared with the overall population, cancer patients are much more likely to be hospitalized (relative risk, 2.77; 95% confidence interval, 2.77–2.78) and to be hospitalized with severe sepsis (relative risk, 3.96; 95% confidence interval, 3.94–3.99). Overall, severe sepsis is associated with 8.5% (46,729) of all cancer deaths at a cost of $3.4 billion per year.

Conclusion

Severe sepsis is a common, deadly, and costly complication in cancer patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002CrossRefPubMed Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002CrossRefPubMed
2.
go back to reference Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, Parsonnet J, Panzer R, Orav EJ, Snydman DR: Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group. JAMA 1997, 278: 234-240. 10.1001/jama.278.3.234CrossRefPubMed Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, Parsonnet J, Panzer R, Orav EJ, Snydman DR: Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group. JAMA 1997, 278: 234-240. 10.1001/jama.278.3.234CrossRefPubMed
3.
go back to reference Zeni F, Freeman B, Natanson C: Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 1997, 25: 1095-1100. 10.1097/00003246-199707000-00001CrossRefPubMed Zeni F, Freeman B, Natanson C: Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 1997, 25: 1095-1100. 10.1097/00003246-199707000-00001CrossRefPubMed
4.
go back to reference Chanock S: Evolving risk factors for infectious complications of cancer therapy. Hematol Oncol Clin North Am 1993, 7: 771-793.PubMed Chanock S: Evolving risk factors for infectious complications of cancer therapy. Hematol Oncol Clin North Am 1993, 7: 771-793.PubMed
5.
go back to reference Allegretta GJ, Weisman SJ, Altman A: Oncologic emergencies II. Hematologic and infectious complications of cancer and cancer treatment. Pediatr Clin North Am 2003, 32: 613-624. Allegretta GJ, Weisman SJ, Altman A: Oncologic emergencies II. Hematologic and infectious complications of cancer and cancer treatment. Pediatr Clin North Am 2003, 32: 613-624.
6.
go back to reference State of Florida: Agency for Health Care Administration Hospital Inpatient Data File. 1999. State of Florida: Agency for Health Care Administration Hospital Inpatient Data File. 1999.
7.
go back to reference The Commonwealth of Massachusetts: Executive Office of Health and Human Services FY 1996 Hospital Case Mix Data Base. 1999. The Commonwealth of Massachusetts: Executive Office of Health and Human Services FY 1996 Hospital Case Mix Data Base. 1999.
8.
go back to reference State of New Jersey: Department of Health and Senior Services Discharge data UB-92 YTD Tape File. 1999. State of New Jersey: Department of Health and Senior Services Discharge data UB-92 YTD Tape File. 1999.
9.
go back to reference State of New York: State of New York Department of Health SPARCS: 'Expanded Administrative Releasable' Data. 1999. State of New York: State of New York Department of Health SPARCS: 'Expanded Administrative Releasable' Data. 1999.
10.
go back to reference State of Virginia: Virginia Health Information Public use file-PUF1 Patient Level Data. 1999. State of Virginia: Virginia Health Information Public use file-PUF1 Patient Level Data. 1999.
11.
go back to reference State of Washington: Department of Health CHARS (Comprehensive Hospital Abstract Reporting System) Public Data File. 1999. State of Washington: Department of Health CHARS (Comprehensive Hospital Abstract Reporting System) Public Data File. 1999.
12.
go back to reference US Bureau of Census: Population Estimates Program. Report CB97-64 Washington, DC: Centers for Medicare and Medicaid Services, US Bureau of Census 1990. US Bureau of Census: Population Estimates Program. Report CB97-64 Washington, DC: Centers for Medicare and Medicaid Services, US Bureau of Census 1990.
14.
go back to reference Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45: 613-619. 10.1016/0895-4356(92)90133-8CrossRefPubMed Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45: 613-619. 10.1016/0895-4356(92)90133-8CrossRefPubMed
15.
go back to reference Microsoft Visual Fox Pro ® Redmond, WA: Microsoft Corporation 1999. Microsoft Visual Fox Pro ® Redmond, WA: Microsoft Corporation 1999.
16.
go back to reference Conlon C: Sepsis in immunocompromised hosts. J R Coll Physicians Lond 2000, 34: 533-536.PubMed Conlon C: Sepsis in immunocompromised hosts. J R Coll Physicians Lond 2000, 34: 533-536.PubMed
17.
go back to reference Bodey GP: Infection in cancer patients. A continuing association. Am J Med 1986, 81: 11-26. 10.1016/0002-9343(86)90510-3CrossRefPubMed Bodey GP: Infection in cancer patients. A continuing association. Am J Med 1986, 81: 11-26. 10.1016/0002-9343(86)90510-3CrossRefPubMed
18.
go back to reference Christakis NA, Escarce JJ: Survival of Medicare patients after enrollment in hospice programs. N Engl J Med 1996, 335: 172-178. 10.1056/NEJM199607183350306CrossRefPubMed Christakis NA, Escarce JJ: Survival of Medicare patients after enrollment in hospice programs. N Engl J Med 1996, 335: 172-178. 10.1056/NEJM199607183350306CrossRefPubMed
19.
go back to reference Hunt RW, Fazekas BS, Luke CG, Priest KR, Roden DM: The coverage of cancer patients by designated palliative services: a population-based study, South Australia,1999. Palliat Med 2002, 16: 403-409. 10.1191/0269216302pm571oaCrossRefPubMed Hunt RW, Fazekas BS, Luke CG, Priest KR, Roden DM: The coverage of cancer patients by designated palliative services: a population-based study, South Australia,1999. Palliat Med 2002, 16: 403-409. 10.1191/0269216302pm571oaCrossRefPubMed
20.
go back to reference Jackson SR, Tweeddale MG, Barnett MJ, Spinelli JJ, Sutherland KJ, Reece DE, Klingemann HG, Nantel SH, Fung HC, Toze CL, Phillips GL, Shepherd JD: Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant 1998, 21: 697-704. 10.1038/sj.bmt.1701158CrossRefPubMed Jackson SR, Tweeddale MG, Barnett MJ, Spinelli JJ, Sutherland KJ, Reece DE, Klingemann HG, Nantel SH, Fung HC, Toze CL, Phillips GL, Shepherd JD: Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant 1998, 21: 697-704. 10.1038/sj.bmt.1701158CrossRefPubMed
21.
go back to reference Huaringa AJ, Leyva FJ, Giralt SA, Blanco J, Signes-Costa J, Velarde H, Champlin RE: Outcome of bone marrow transplantation patients requiring mechanical ventilation. Crit Care Med 2000, 28: 1014-1017. 10.1097/00003246-200004000-00017CrossRefPubMed Huaringa AJ, Leyva FJ, Giralt SA, Blanco J, Signes-Costa J, Velarde H, Champlin RE: Outcome of bone marrow transplantation patients requiring mechanical ventilation. Crit Care Med 2000, 28: 1014-1017. 10.1097/00003246-200004000-00017CrossRefPubMed
22.
go back to reference Chen K, Varon J, Wenker OC: Malignant airway obstruction: recognition and management. J Emerg Med 1998, 16: 83-92. 10.1016/S0736-4679(97)00245-XCrossRefPubMed Chen K, Varon J, Wenker OC: Malignant airway obstruction: recognition and management. J Emerg Med 1998, 16: 83-92. 10.1016/S0736-4679(97)00245-XCrossRefPubMed
23.
go back to reference Brown ML, Lipscomb J, Snyder C: The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health 2001, 22: 91-113. 10.1146/annurev.publhealth.22.1.91CrossRefPubMed Brown ML, Lipscomb J, Snyder C: The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health 2001, 22: 91-113. 10.1146/annurev.publhealth.22.1.91CrossRefPubMed
24.
go back to reference Studnicki J, Schapira DV, Straumfjord JV, Clark RA, Marshburn J, Weiner DC: A national profile of the use of intensive care by Medicare patients with cancer. Cancer 1994, 74: 2366-2373.CrossRefPubMed Studnicki J, Schapira DV, Straumfjord JV, Clark RA, Marshburn J, Weiner DC: A national profile of the use of intensive care by Medicare patients with cancer. Cancer 1994, 74: 2366-2373.CrossRefPubMed
25.
go back to reference Rosenman M, Madsen K, Hui S, Breitfeld PP: Modeling administrative outcomes in fever and neutropenia: clinical variables significantly influence length of stay and hospital charges. J Pediatr Hematol Oncol 2003, 24: 263-268. 10.1097/00043426-200205000-00009CrossRef Rosenman M, Madsen K, Hui S, Breitfeld PP: Modeling administrative outcomes in fever and neutropenia: clinical variables significantly influence length of stay and hospital charges. J Pediatr Hematol Oncol 2003, 24: 263-268. 10.1097/00043426-200205000-00009CrossRef
26.
go back to reference Astier MP, Mayordomo JI, Abad JM, Gomez LT, Tres A: Cost-analysis of high-dose chemotherapy and peripheral blood stem-cell support in patients with solid tumors. Ann Oncol 2000, 11: 603-606. 10.1023/A:1008392412590CrossRefPubMed Astier MP, Mayordomo JI, Abad JM, Gomez LT, Tres A: Cost-analysis of high-dose chemotherapy and peripheral blood stem-cell support in patients with solid tumors. Ann Oncol 2000, 11: 603-606. 10.1023/A:1008392412590CrossRefPubMed
27.
go back to reference Schapira DV, Studnicki J, Bradham DD, Wolff P, Jarrett A: Intensive care, survival, and expense of treating critically ill cancer patients. JAMA 1993, 269: 783-786. 10.1001/jama.269.6.783CrossRefPubMed Schapira DV, Studnicki J, Bradham DD, Wolff P, Jarrett A: Intensive care, survival, and expense of treating critically ill cancer patients. JAMA 1993, 269: 783-786. 10.1001/jama.269.6.783CrossRefPubMed
28.
go back to reference Groeger JS, Aurora RN: Intensive care, mechanical ventilation, dialysis, and cardiopulmonary resuscitation. Implications for the patient with cancer. Crit Care Clin 2001, 17: 791-803.CrossRefPubMed Groeger JS, Aurora RN: Intensive care, mechanical ventilation, dialysis, and cardiopulmonary resuscitation. Implications for the patient with cancer. Crit Care Clin 2001, 17: 791-803.CrossRefPubMed
29.
go back to reference Klastersky J: Intensive care support in oncology: a contradiction? [Editorial]. Support Care Cancer 1995,3(2):88.CrossRefPubMed Klastersky J: Intensive care support in oncology: a contradiction? [Editorial]. Support Care Cancer 1995,3(2):88.CrossRefPubMed
30.
go back to reference Porter GA, Skibber JM: Outcomes research in surgical oncology. Ann Surg Oncol 2003, 7: 367-375.CrossRef Porter GA, Skibber JM: Outcomes research in surgical oncology. Ann Surg Oncol 2003, 7: 367-375.CrossRef
31.
Metadata
Title
Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care
Authors
Mark D Williams
Lee Ann Braun
Liesl M Cooper
Joseph Johnston
Richard V Weiss
Rebecca L Qualy
Walter Linde-Zwirble
Publication date
01-10-2004
Publisher
BioMed Central
Published in
Critical Care / Issue 5/2004
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc2893

Other articles of this Issue 5/2004

Critical Care 5/2004 Go to the issue